Toremifene

CHEMBL1655 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

406.0 g/mol

LogP

7.2

Phase

4

This selective estrogen receptor modulator (SERM) is used to treat metastatic breast cancer in postmenopausal women whose tumors are estrogen receptor-positive. Like tamoxifen, it works by competing with estrogen to bind to its receptors in breast cancer cells, slowing their growth. It may slightly increase the risk of uterine cancer and blood clots with long-term use.

الوزن الجزيئي

406,0000 g/mol

LogP

7,20

TPSA

12,50 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Osteoporosis Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1

InChI

InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-

Molecular Formula

C26H28ClNO

HBD / HBA

- / 2

الروابط القابلة للدوران

9

الذرات الثقيلة

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This selective estrogen receptor modulator (SERM) is used to treat metastatic breast cancer in postmenopausal women whose tumors are estrogen receptor-positive. Like tamoxifen, it works by competing with estrogen to bind to its receptors in breast cancer cells, slowing their growth. It may slightly increase the risk of uterine cancer and blood clots with long-term use.

Yes, Toremifene is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1655. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3005573. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Toremifene على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C26H28ClNO
المرادفات: 1

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.